InsiderTrades

Form 4 for ORMP ORAMED PHARMACEUTICALS INC.

Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001213900-22-000802 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-01-05 2022-01-03 ORMP Friedman Aviad Dir G - Gift $0.00 -6,000 0 -100% $0
D 2022-01-05 2022-01-03 ORMP Friedman Aviad Dir A - Grant — +6,000 6,000 New —
D 2022-01-05 2022-01-03 ORMP Friedman Aviad Dir A - Grant $0.00 +10.0K 10.0K New $0
D 2022-01-05 2022-01-03 ORMP Friedman Aviad Dir G - Gift $0.00 -10.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-03 G D 6,000 $0.00 0 D — —
2 Common Common Stock 2022-01-03 A A 6,000 — 6,000 D — — (F1) Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
3 Derivative Stock Option (right to buy 2022-01-03 A A 10,000 $0.00 10,000 D $13.89 · — to 2032-01-03 10,000 Common Stock (F3) The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.
4 Derivative Stock Option (right to buy 2022-01-03 G D 10,000 $0.00 0 D $13.89 · — to 2032-01-03 10,000 Common Stock (F3) The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.